Literature DB >> 939054

Report of nine cases of accidental injury to man with Freund's complete adjuvant.

H M Chapel, P J August.   

Abstract

Nine cases of accidental injury with Freund's complete adjuvant to man are reported. One case is reported in detail and the other eight have been seen and reviewed retrospectively. Reactions developed in Mantoux positive individuals, who injected Freund's complete adjuvant with another protein. However, not all such injections produced the reaction. Treatment was unsuccessful, although one reaction may have been aborted by early surgical excision of the site of injection.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 939054      PMCID： PMC1538531     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  7 in total

1.  Autogenous vaccine in cancer patients.

Authors:  J B GRAHAM; R M GRAHAM
Journal:  Surg Gynecol Obstet       Date:  1962-01

2.  Studies in tumor autoimmunity.

Authors:  J W FINNEY; E H BYERS; R H WILSON
Journal:  Cancer Res       Date:  1960-04       Impact factor: 12.701

3.  Letter: B.C.G. and immunological anergy.

Authors:  G Lamoureux; R Poisson
Journal:  Lancet       Date:  1974-05-18       Impact factor: 79.321

4.  Letter: Clindamycin and pseudomembranous colitis.

Authors:  R F Wells; L E Cohen; C J McNeill
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

5.  Koch's phenomenon involving the flexor tendon sheath. Adjuvant-induced tenosynovitis in man.

Authors:  H B Conklin; R M Curtis; S Ben-Efraim
Journal:  J Bone Joint Surg Am       Date:  1969-10       Impact factor: 5.284

6.  Letter: Accidental injection of Freund's adjuvant.

Authors:  E M Berry; D Geltner; T Chajek
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

7.  A study in clinical cancer immunotherapy.

Authors:  L E Hughes; R Kearney; M Tully
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860
  7 in total
  4 in total

1.  Intramuscular injection of antigens and adjuvant preferentially decreases 18:2n-6 and 18:3n-3 in pig neck muscle.

Authors:  Richard P Bazinet; Holly Douglas; Ewen G McMillan; Bruce N Wilkie; Stephen C Cunnane
Journal:  Lipids       Date:  2003-12       Impact factor: 1.880

2.  Glucan particles as a novel adjuvant for the induction of experimental autoimmune encephalomyelitis.

Authors:  Carol Chase Huizar; Niannian Ji; Robert Reddick; Gary R Ostroff; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2021-05-21       Impact factor: 4.178

3.  GM-CSF-loaded chitosan hydrogel as an immunoadjuvant enhances antigen-specific immune responses with reduced toxicity.

Authors:  Kyung Hee Noh; Yeong Min Park; Hyuk Soon Kim; Tae Heung Kang; Kwon-Ho Song; Young-Ho Lee; Yeongseon Byeon; Hat Nim Jeon; In Duk Jung; Byung Cheol Shin; Kyung-Mi Lee; Seung-Yong Seong; Hee Dong Han; Tae Woo Kim
Journal:  BMC Immunol       Date:  2014-10-18       Impact factor: 3.615

4.  Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Authors:  Suparna Mazumder; Valerie Swank; Nina Dvorina; Justin M Johnson; Vincent K Tuohy
Journal:  Clin Exp Vaccine Res       Date:  2022-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.